Address
Form of workAbout City of Hope
City of Hope is an independent research and treatment center for diabetes, cancer and other life-threatening diseases. Bringing together the best in bench-to bedside research, City of Hope's Arthur Riggs Diabetes & Metabolism Research Institute (AR-DMRI) is one of the world's most comprehensive diabetes research programs.
City of Hope has a long and impressive history of groundbreaking discoveries in the field of diabetes spanning more than five decades since RachmielLevine, M.D., who discovered the role of insulin in glucose transport, launched diabetes research at City of Hope in the 1970s. The Institute is named for ArthurD.Riggs, Ph.D., another pioneer in the field famous for his work on synthesizing the first man-made gene and using synthetic genes to produce human insulin, now the standard of care for people with diabetes worldwide. The AR-DMRI is headed by Debbie Thurmond, Ph.D., a renowned research scientist,professor and founding chair of the Department of Molecular & Cellular Endocrinology.
City of Hope is also home to seminal National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) programs, such as the Human Islet Research Network (HIRN) and the Integrated Islet Distribution Program (IIDP), that lead the field of diabetes in diabetes research and translational potential.
City of Hope is located in Los Angeles, California, with community clinics throughout Southern California. It recently acquired Cancer Treatment Centers of America, extending its national reach. One of only 53 NCI-designated comprehensive cancer centers in the nation, it has been ranked as one of "America's Best Hospitals" in cancer by U.S. News & World Report for over 15 years. Founded in 1913, City of Hope is a pioneer in the fields of immunotherapy and clinical islet cell transplantation for diabetes, bone marrow transplantation and numerous breakthrough cancer drugs, many based on technology developed at the institution.
City of Hope's commitment to Diversity, Equity and Inclusion
We believe diversity, equity and inclusion is key in serving our mission to provide compassionate patient care, drive innovative discovery, and advance vital education focused on eliminating cancer and diabetes in all of our communities. Our commitment to Diversity, Equity and Inclusion ensures we bring the full range of skills, perspectives, cultural backgrounds and experiences to our work -- and that our teams align with the people we serve in order to build trust and understanding. We are dedicated to fostering a community that embraces diversity - in ideas, backgrounds and perspectives; this is reflected in our work and represented in our people.
Position Summary
A Tenured-track Assistant Professor opportunity is immediately available in the Department of Molecular and Cellular Endocrinology within the Arthur Riggs Diabetes & Metabolism Research Institute (AR-DMRI). AR-DMRI is a component of the Beckman Research Institute (BRI) at City of Hope. Our research depth in diabetes and cancer makes this institution unique, providing opportunities for scientific and clinical distinction and collaboration across disciplines, for example crosstalk between endocrinology, diabetes, cancer metabolism, and biology of the pancreatic islet, muscle, liver, and adipose tissue.
The Department of Molecular and Cellular Endocrinology, directed by Adolfo Garcia-Ocana, PhD who joined City of Hope in March 2023 is being expanded with a strong focus on diabetes and translation.
The successful candidate will be a scientist with an interest in broadly understanding Diabetes Pathogenesis and with the idea of translating promising insights into biomarkers, treatments and potential cures for type 1 and type 2 diabetes.
Qualifications
Applicants must have an earned doctoral degree (PhD and / or MD) and possess a record of scholarly accomplishments (high-impact publications, extramural funding, national recognition) commensurate to the Assistant Professor rank.
Applicants will have excellent interpersonal and communication skills and an open, collaborative mindset.
Mentoring and teaching skills.
Interdisciplinary and inter-institutional collaborations.
Integrity, honesty, and inclusive behavior.
Additional Information:
As a condition of employment, City of Hope requires staff to comply with all state and federal vaccination mandates.
For more information on the Arthur Riggs Diabetes & Metabolism Research Institute please visit here (https://www.cityofhope.org/research/riggs-institute) .
For more information on the Department of Molecular and Cellular Endocrinology at AR-DMRI please visit here (https://www.cityofhope.org/research/riggs-institute/molecular-and-cellular-endocrinology) .
The estimated pay scale represents the typical [salary/hourly] range City of Hope reasonably expects to pay for this position, with offers determined based on several factors which may include, but not be limited to, the candidate's experience, expertise, skills, education, job scope, training, internal equity, geography/market, etc. This pay scale is subject to change from time to time.
City of Hope is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, religion, color, national origin, sex, sexual orientation, gender identity, age, status as a protected veteran, or status as a qualified individual with disability.
